论文部分内容阅读
目的观察乳杆菌活菌胶囊治疗产后细菌性阴道病(BV)的有效性。方法按Amsel标准对600例产后6-8周妇女进行BV筛查,将确诊BV的356例产妇(哺乳妇女174例,未哺乳妇女182例)随机分为两组:A组178例,采用定君生胶囊阴道给药治疗;B组178例,采用复方甲硝唑栓阴道给药治疗。均连续用药10d,停药7d后复查。选600名正常育龄妇女为对照组。结果产后6-8周妇女BV检出率为59.33%(356/600),明显高于对照组的19.33%(116/600)(P<0.05)。A组治疗BV的总有效率为92.70%,B组为92.13%(P>0.05)。结论产后6-8周妇女BV发病率较高,乳杆菌活菌胶囊能有效改善阴道内生态环境,安全、有效,易为产妇所接受。
Objective To observe the effectiveness of Lactobacillus live capsule in the treatment of postpartum bacterial vaginosis (BV). Methods According to the Amsel standard, 600 women with postnatal period of 6-8 weeks were screened for BV. 356 women (174 breastfeeding women and 182 breastfeeding women) with confirmed BV were randomly divided into two groups: group A (178 cases) Jun Sheng capsule vaginal administration; B group of 178 cases, the use of compound metronidazole suppository vaginal administration. Continuous medication 10d, withdrawal after 7d review. 600 normal women of childbearing age were selected as the control group. Results The detection rate of BV was 59.33% (356/600) in women 6-8 weeks postpartum, which was significantly higher than that in control group (19.33%, 116/600) (P <0.05). The total effective rate of group A was 92.70% for treatment of BV, 92.13% for group B (P> 0.05). Conclusions The incidence of BV was high in women 6-8 weeks postpartum. Lactobacillus live capsule could effectively improve vaginal environment and was safe and effective. It was easy for maternal acceptance.